Wolfgang Eberlein

2.4k total citations
27 papers, 2.0k citations indexed

About

Wolfgang Eberlein is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Organic Chemistry. According to data from OpenAlex, Wolfgang Eberlein has authored 27 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Molecular Biology, 13 papers in Cellular and Molecular Neuroscience and 3 papers in Organic Chemistry. Recurrent topics in Wolfgang Eberlein's work include Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (12 papers) and Chemical Synthesis and Analysis (4 papers). Wolfgang Eberlein is often cited by papers focused on Receptor Mechanisms and Signaling (12 papers), Neuropeptides and Animal Physiology (12 papers) and Chemical Synthesis and Analysis (4 papers). Wolfgang Eberlein collaborates with scholars based in Germany, Switzerland and Canada. Wolfgang Eberlein's co-authors include K Rudolf, Henri Doods, Wolfhard Engel, Michael Entzeroth, H. Wieland, W. Engel, Wolfgang Wienen, Dongmei Wu, Annette G. Beck‐Sickinger and Klaus‐Dieter Willim and has published in prestigious journals such as Journal of Medicinal Chemistry, Journal of Pharmacology and Experimental Therapeutics and British Journal of Pharmacology.

In The Last Decade

Wolfgang Eberlein

27 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Wolfgang Eberlein Germany 20 1.4k 1.1k 353 345 280 27 2.0k
Wolfhard Engel Germany 15 917 0.7× 733 0.7× 199 0.6× 330 1.0× 232 0.8× 18 1.6k
Gordon S. Baxter United States 22 1.1k 0.8× 943 0.9× 112 0.3× 129 0.4× 351 1.3× 27 2.0k
Christopher R. Snell United States 25 960 0.7× 1.3k 1.2× 137 0.4× 529 1.5× 213 0.8× 86 2.3k
Susan L. Gackenheimer United States 23 1.0k 0.7× 959 0.9× 270 0.8× 92 0.3× 107 0.4× 38 1.6k
William B. Mathews United States 28 1.7k 1.2× 938 0.9× 148 0.4× 185 0.5× 178 0.6× 88 3.2k
Stafford McLean United States 30 1.9k 1.4× 1.6k 1.5× 175 0.5× 160 0.5× 616 2.2× 68 2.9k
Didier Pélaprat France 29 1.5k 1.1× 1.3k 1.2× 182 0.5× 51 0.1× 167 0.6× 72 2.3k
C. Garret France 24 1.2k 0.9× 926 0.9× 53 0.2× 190 0.6× 404 1.4× 59 1.6k
Nina Mohell Sweden 27 1.0k 0.8× 1.1k 1.1× 131 0.4× 266 0.8× 517 1.8× 65 2.2k
Jacob M. Hiller United States 30 2.5k 1.8× 2.2k 2.1× 146 0.4× 78 0.2× 674 2.4× 81 3.1k

Countries citing papers authored by Wolfgang Eberlein

Since Specialization
Citations

This map shows the geographic impact of Wolfgang Eberlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wolfgang Eberlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wolfgang Eberlein more than expected).

Fields of papers citing papers by Wolfgang Eberlein

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wolfgang Eberlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wolfgang Eberlein. The network helps show where Wolfgang Eberlein may publish in the future.

Co-authorship network of co-authors of Wolfgang Eberlein

This figure shows the co-authorship network connecting the top 25 collaborators of Wolfgang Eberlein. A scholar is included among the top collaborators of Wolfgang Eberlein based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Wolfgang Eberlein. Wolfgang Eberlein is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Doods, Henri, Dongmei Wu, Michael Entzeroth, et al.. (2000). Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist. British Journal of Pharmacology. 129(3). 420–423. 386 indexed citations
2.
Wu, Dongmei, et al.. (2000). Characterisation of calcitonin gene-related peptide receptors in rat atrium and vas deferens: evidence for a [Cys(Et)2,7]hCGRP-preferring receptor. European Journal of Pharmacology. 400(2-3). 313–319. 47 indexed citations
3.
Doods, Henri, Wolfram Gaida, H. Wieland, et al.. (1999). BIIE0246 選択的で高親和性のニューロペプチドY Y 2 受容体きっ抗薬. European Journal of Pharmacology. 384. 3–5. 5 indexed citations
4.
Doods, Henri, Wolfram Gaida, H. Wieland, et al.. (1999). BIIE0246: A selective and high affinity neuropeptide Y Y2 receptor antagonist. European Journal of Pharmacology. 384(2-3). R3–R5. 170 indexed citations
5.
Wieland, H., W. Engel, Wolfgang Eberlein, K Rudolf, & Henri Doods. (1998). Subtype selectivity of the novel nonpeptide neuropeptide Y Y1 receptor antagonist BIBO 3304 and its effect on feeding in rodents. British Journal of Pharmacology. 125(3). 549–555. 220 indexed citations
6.
Sautel, Martine, K Rudolf, Helmut Wittneben, et al.. (1996). Neuropeptide Y and the nonpeptide antagonist BIBP 3226 share an overlapping binding site at the human Y1 receptor.. Molecular Pharmacology. 50(2). 285–292. 82 indexed citations
7.
Doods, Henri, H. Wieland, Wolfhard Engel, et al.. (1996). BIBP 3226, the first selective neuropeptide Y1 receptor antagonist: A review of its pharmacological properties. Regulatory Peptides. 65(1). 71–77. 112 indexed citations
8.
Entzeroth, Michael, Wolfgang Eberlein, Wolfhard Engel, et al.. (1995). Labeling of neuropeptide Y receptors in SK-N-MC cells using the novel, nonpeptide Y1 receptor-selective antagonist [3H]BIBP3226. European Journal of Pharmacology. 278(3). 239–242. 32 indexed citations
9.
Doods, Henri, Wolfgang Wienen, Michael Entzeroth, et al.. (1995). Pharmacological characterization of the selective nonpeptide neuropeptide Y Y1 receptor antagonist BIBP 3226.. Journal of Pharmacology and Experimental Therapeutics. 275(1). 136–142. 111 indexed citations
10.
Rudolf, K, Wolfgang Eberlein, Wolfhard Engel, et al.. (1994). The first highly potent and selective non-peptide neuropeptide Y Y1 receptor antagonist: BIBP3226. European Journal of Pharmacology. 271(2-3). R11–R13. 337 indexed citations
11.
Schiavi, G.B., Lucilla D. Monti, Klaus Mendla, et al.. (1993). Distribution of the muscarinic receptor subtypes in rat olfactory bulb as determined with three selective second generation antagonists DAU 6202, AQ-RA 741 and DAG 5600. Life Sciences. 52(5-6). 572–572. 2 indexed citations
12.
Doods, H. N., Rémi Quirion, Gerhard Mihm, et al.. (1993). Therapeutic potential of CNS-active M2 antagonists: Novel structures and pharmacology. Life Sciences. 52(5-6). 497–503. 58 indexed citations
13.
14.
Eberlein, Wolfgang, et al.. (1990). AQ-RA-741. Drugs of the Future. 15(8). 786–786. 1 indexed citations
15.
Engel, Wolfhard, et al.. (1989). Tricyclic compounds as selective muscarinic receptor antagonists. 3. Structure-selectivity relationships in a series of cardioselective (M2) antimuscarinics. Journal of Medicinal Chemistry. 32(8). 1718–1724. 34 indexed citations
16.
Eberlein, Wolfgang, et al.. (1988). Tricyclic compounds as selective antimuscarinics. 2. Structure-activity relationships of M1-selective antimuscarinics related to pirenzepine. Journal of Medicinal Chemistry. 31(6). 1169–1174. 25 indexed citations
17.
Eberlein, Wolfgang, et al.. (1977). [Anti-ulcer agent pirenzepine (LS 519)--a tricyclic compound with particular physico-chemical properties (author's transl)].. PubMed. 27(2). 356–9. 6 indexed citations
18.
Eberlein, Wolfgang, et al.. (1972). Steroidische Cardiotonica, I Einführung von Substituenten in den Butenolid‐Ring von Herzglykosiden. Chemische Berichte. 105(11). 3686–3694. 24 indexed citations
19.
Liptay, W., et al.. (1968). Über das Elektronenspektrum von Fluorenon Beobachtung einer durch ein elektrisches Feld induzierten Absorptionsbande. Zeitschrift für Naturforschung A. 23(3). 377–393. 21 indexed citations
20.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wolfhard Engel Breakdown of academic impact, for papers by Gordon S. Baxter Breakdown of academic impact, for papers by Christopher R. Snell Breakdown of academic impact, for papers by Susan L. Gackenheimer Breakdown of academic impact, for papers by William B. Mathews Breakdown of academic impact, for papers by Stafford McLean Breakdown of academic impact, for papers by Didier Pélaprat Breakdown of academic impact, for papers by C. Garret Breakdown of academic impact, for papers by Nina Mohell Breakdown of academic impact, for papers by Jacob M. Hiller
Rankless by CCL
2026